Specifically, tumors disrupt the immune response surveillance and cytotoxicity by using two major mechanisms mediated by the Wnt/β-catenin signaling pathway: 1) they promote the differentiation and activity of Treg cells, and 2) they minimize the infiltration of CD8+ T cells into the tumor microenvironment 9, 10. The gene discussed is CD8A; the disease is neoplasm.